These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 19302593)

  • 1. Anti-angiogenic and vascular disrupting effects of C9, a new microtubule-depolymerizing agent.
    Ren X; Dai M; Lin LP; Li PK; Ding J
    Br J Pharmacol; 2009 Apr; 156(8):1228-38. PubMed ID: 19302593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deoxypodophyllotoxin exerts both anti-angiogenic and vascular disrupting effects.
    Jiang Z; Wu M; Miao J; Duan H; Zhang S; Chen M; Sun L; Wang Y; Zhang X; Zhu X; Zhang L
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1710-9. PubMed ID: 23702033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular disrupting activity of combretastatin analogues.
    Porcù E; Salvador A; Primac I; Mitola S; Ronca R; Ravelli C; Bortolozzi R; Vedaldi D; Romagnoli R; Basso G; Viola G
    Vascul Pharmacol; 2016 Aug; 83():78-89. PubMed ID: 27235861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models.
    Wu XY; Xu H; Wu ZF; Chen C; Liu JY; Wu GN; Yao XQ; Liu FK; Li G; Shen L
    Oncotarget; 2015 Dec; 6(42):44563-78. PubMed ID: 26575424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPemd26, an anthraquinone derivative, suppresses angiogenesis via inhibiting VEGFR2 signalling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Br J Pharmacol; 2014 Dec; 171(24):5728-42. PubMed ID: 25091695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morelloflavone, a biflavonoid, inhibits tumor angiogenesis by targeting rho GTPases and extracellular signal-regulated kinase signaling pathways.
    Pang X; Yi T; Yi Z; Cho SG; Qu W; Pinkaew D; Fujise K; Liu M
    Cancer Res; 2009 Jan; 69(2):518-25. PubMed ID: 19147565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focal adhesion kinase is activated by microtubule-depolymerizing agents and regulates membrane blebbing in human endothelial cells.
    Zheng YB; Gong JH; Zhen YS
    J Cell Mol Med; 2020 Jul; 24(13):7228-7238. PubMed ID: 32452639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoprostanes inhibit vascular endothelial growth factor-induced endothelial cell migration, tube formation, and cardiac vessel sprouting in vitro, as well as angiogenesis in vivo via activation of the thromboxane A(2) receptor: a potential link between oxidative stress and impaired angiogenesis.
    Benndorf RA; Schwedhelm E; Gnann A; Taheri R; Kom G; Didié M; Steenpass A; Ergün S; Böger RH
    Circ Res; 2008 Oct; 103(9):1037-46. PubMed ID: 18802021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel tubulin antagonist pretubulysin displays antivascular properties in vitro and in vivo.
    Kretzschmann VK; Gellrich D; Ullrich A; Zahler S; Vollmar AM; Kazmaier U; Fürst R
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):294-303. PubMed ID: 24285578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-angiogenic properties of a sulindac analogue.
    Pyriochou A; Tsigkos S; Vassilakopoulos T; Cottin T; Zhou Z; Gourzoulidou E; Roussos C; Waldmann H; Giannis A; Papapetropoulos A
    Br J Pharmacol; 2007 Dec; 152(8):1207-14. PubMed ID: 17965739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfated fucoidan FP08S2 inhibits lung cancer cell growth in vivo by disrupting angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling.
    Chen H; Cong Q; Du Z; Liao W; Zhang L; Yao Y; Ding K
    Cancer Lett; 2016 Nov; 382(1):44-52. PubMed ID: 27569654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-angiogenic and anti-inflammatory properties of kahweol, a coffee diterpene.
    Cárdenas C; Quesada AR; Medina MA
    PLoS One; 2011; 6(8):e23407. PubMed ID: 21858104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer.
    Hong SW; Jung KH; Park BH; Zheng HM; Lee HS; Choi MJ; Yun JI; Kang NS; Lee J; Hong SS
    Cancer Lett; 2013 May; 332(1):74-82. PubMed ID: 23348694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TR-644 a novel potent tubulin binding agent induces impairment of endothelial cells function and inhibits angiogenesis.
    Porcù E; Viola G; Bortolozzi R; Persano L; Mitola S; Ronca R; Presta M; Romagnoli R; Baraldi PG; Basso G
    Angiogenesis; 2013 Jul; 16(3):647-62. PubMed ID: 23456551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-angiogenic quassinoid-rich fraction from Eurycoma longifolia modulates endothelial cell function.
    Al-Salahi OS; Kit-Lam C; Majid AM; Al-Suede FS; Mohammed Saghir SA; Abdullah WZ; Ahamed MB; Yusoff NM
    Microvasc Res; 2013 Nov; 90():30-9. PubMed ID: 23899415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nobiletin, a citrus polymethoxyflavonoid, suppresses multiple angiogenesis-related endothelial cell functions and angiogenesis in vivo.
    Kunimasa K; Ikekita M; Sato M; Ohta T; Yamori Y; Ikeda M; Kuranuki S; Oikawa T
    Cancer Sci; 2010 Nov; 101(11):2462-9. PubMed ID: 20670297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the tyrosine phosphatase SHP-2 suppresses angiogenesis in vitro and in vivo.
    Mannell H; Hellwig N; Gloe T; Plank C; Sohn HY; Groesser L; Walzog B; Pohl U; Krotz F
    J Vasc Res; 2008; 45(2):153-63. PubMed ID: 17962719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinazoline analog HMJ-30 inhibits angiogenesis: involvement of endothelial cell apoptosis through ROS-JNK-mediated death receptor 5 signaling.
    Lu CC; Chen HP; Chiang JH; Jin YA; Kuo SC; Wu TS; Hour MJ; Yang JS; Chiu YJ
    Oncol Rep; 2014 Aug; 32(2):597-606. PubMed ID: 24919794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractalkine stimulates angiogenesis by activating the Raf-1/MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways.
    Lee SJ; Namkoong S; Kim YM; Kim CK; Lee H; Ha KS; Chung HT; Kwon YG; Kim YM
    Am J Physiol Heart Circ Physiol; 2006 Dec; 291(6):H2836-46. PubMed ID: 16877565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of angiogenesis by a tenascin-c peptide which is capable of activating beta1-integrins.
    Saito Y; Shiota Y; Nishisaka M; Owaki T; Shimamura M; Fukai F
    Biol Pharm Bull; 2008 May; 31(5):1003-7. PubMed ID: 18451535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.